| Authors: |
Nguyen HT; Research Department, FIT RD Social Enterprise Company Limited (FIT RD), Hanoi, Vietnam.; Division of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, Sweden., Vo LNQ; Management, Friends for International TB Relief, Hanoi, Vietnam.; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden., Codlin AJ; Management, Friends for International TB Relief, Hanoi, Vietnam.; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden., Forse R; Management, Friends for International TB Relief, Hanoi, Vietnam.; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden., Wingfield T; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.; Centre for Tuberculosis Research, Departments of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Tropical and Infectious Diseases Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom., Annerstedt KS; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden., MacLean EL; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Creswell J; TB REACH, Stop TB Partnership, Geneva, Switzerland., Kirubi B; TB REACH, Stop TB Partnership, Geneva, Switzerland., Nguyen HB; Research Centre, Vietnam National Lung Hospital, Hanoi, Vietnam., Van Dinh L; Research Centre, Vietnam National Lung Hospital, Hanoi, Vietnam., Doan HT; Research Centre, Vietnam National Lung Hospital, Hanoi, Vietnam., Forsman LD; Division of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. |